4-(3,4-二氟苯氧基)苯胺 | 383126-84-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(3,4-二氟苯氧基)苯胺
• 英文名称: 4-(3,4-difluoro-phenoxy)-phenylamine
• 英文别名: 4-(3,4-Difluorophenoxy)aniline
• CAS: 383126-84-9
• 化学式: C₁₂H₉F₂NO
• mdl: MFCD02663360
• 分子量: 221.206
• InChiKey: IUXWEGLCUFEKGP-UHFFFAOYSA-N

物化性质

• 沸点：
  316.1±42.0 °C(Predicted)
• 密度：
  1.295±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 包装等级：
  III
• 危险类别：
  9
• 危险性防范说明：
  P261,P264,P270,P272,P273,P280,P301+P312+P330,P302+P352,P305+P351+P338+P310,P333+P313,P391,P501
• 危险品运输编号：
  3077
• 危险性描述：
  H302,H317,H318,H410

反应信息

• 作为反应物：
  描述：

  4-(3,4-二氟苯氧基)苯胺 在 palladium on activated charcoal 氢气 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 (S)-2-Amino-N-[4-(3,4-difluoro-phenoxy)-phenyl]-succinamic acid
  参考文献：
  名称：

  Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2

  摘要：

  Excitatory amino acid transporters (EAATs) play a pivotal role in maintaining glutamate homeostasis in the mammalian central nervous system, with the EAAT-2 subtype thought to be responsible for the bulk of the glutamate uptake in forebrain regions. A complete elucidation of the functional role of EAAT-2 has been hampered by the lack of potent and selective pharmacological tools. In this study, we describe the synthesis and biological activities of novel aryl-ether, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT-2. Compound (16) represents one of the most potent (IC50 = 85 +/- 5 nM) and selective inhibitors of EAAT-2 identified to date. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.003

文献信息

• [EN] INHIBITORS OF BRUTON'S TYROSINE KINASE<br/>[FR] INHIBITEURS DE LA TYROSINE KINASE DE BRUTON
  申请人：HOFFMANN LA ROCHE

  公开号：WO2015086636A1

  公开（公告）日：2015-06-18

  This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are useful for the treatment of oncological, auto-immune, and inflammatory diseases caused by aberrant B-cell activation. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient.

  该应用程序根据通用公式（I）披露化合物：其中所有变量的定义如本文所述，这些化合物抑制Btk。本文披露的化合物对调节Btk的活性并治疗与过度Btk活性相关的疾病有用。这些化合物对于治疗由异常B细胞活化引起的肿瘤学、自身免疫和炎症性疾病是有用的。还披露了含有公式I化合物和至少一种载体、稀释剂或赋形剂的组合物。
• INDOLE AMIDE COMPOUND AS INHIBITOR OF NECROSIS
  申请人：LG LIFE SCIENCES LTD.

  公开号：US20160194313A1

  公开（公告）日：2016-07-07

  The present invention relates to an indole amide compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.

  本发明涉及一种由式（1）所表示的吲哚酰胺化合物、其药学上可接受的盐或异构体、用于预防或治疗坏死和坏死相关疾病的组合物，以及制备该组合物的方法，该组合物包括吲哚化合物或其药学上可接受的盐或异构体作为活性成分。
• INHIBITORS OF BRUTON'S TYROSINE KINASE
  申请人：F.Hoffmann-La Roche AG

  公开号：EP3080098A1

  公开（公告）日：2016-10-19
• US9802920B2
  申请人：——

  公开号：US9802920B2

  公开（公告）日：2017-10-31
• US9868731B2
  申请人：——

  公开号：US9868731B2

  公开（公告）日：2018-01-16